We estimate that MRD represents a $20+ billion addressable market, growing at 30% annually, which we believe is less than 10% penetrated FORT MYERS,...

A novel DNA-based therapy combined with gemcitabine chemotherapy has demonstrated encouraging survival outcomes in patients with platinum-resistant...

“These improvements significantly reduce the amount of time each patient spends on the treatment table, while at the same time increasing treatment...

“These improvements significantly reduce the amount of time each patient spends on the treatment table, while at the same time increasing treatment...

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor...

James McPherson went for a CT scan after forgetting routes while responding to fire calls.

WEDNESDAY, Feb. 18, 2026 -- In guidelines published in the February issue of the Annals of Oncology, updated recommendations are presented for a...

WEDNESDAY, Feb. 18, 2026 -- In guidelines published in the February issue of the Annals of Oncology, updated recommendations are presented for a...

Immunotherapy – which activates the body's own immune system to kill cancer cells – has not worked well against a rare and fatal liver cancer, but...

More than 5,000 Australian cancer sufferers can now get cheap access to lifesaving immunotherapy drugs that previously cost some patients more than...